← Back to Search

Thrombectomy Device

Patients with ischemic stroke for Ischemic Stroke (INSIGHT Trial)

N/A
Waitlist Available
Research Sponsored by Penumbra Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up blood and clot specimen obtained during procedure
Awards & highlights

Summary

The aim of the study is to collect and analyze specimen from ischemic stroke patients undergoing thrombectomy procedures and from patients undergoing minimally invasive surgery for intracranial hematoma evacuation.

Eligible Conditions
  • Ischemic Stroke
  • Stroke
  • Brain Hematoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~clot specimen obtained during procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and clot specimen obtained during procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood and clot specimen genomics
Blood and clot specimen proteomics
Blood and clot specimen transcriptomics
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Patients with ischemic strokeExperimental Treatment1 Intervention
Group II: Patients with intracranial hematomaExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Penumbra Inc.Lead Sponsor
36 Previous Clinical Trials
9,210 Total Patients Enrolled
10 Trials studying Ischemic Stroke
2,493 Patients Enrolled for Ischemic Stroke
~87 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top